“An entire industry is about to be wiped out”

According to Jennie Ekbeck, CEO of Umeå Biotech Incubators, Sweden risks not having any small diagnostic companies left in five years.

Lucy Robertshaw: Did you know Stockholm wants to be in top 5 in the world for Life Sciences?

Karolinska Institutet Solna Campus has certainly become the next “Kendall Square”, writes Lucy Robertshaw in a column.

Skrubben bakom Nobelprisupptäckten

Det hör inte till vanligheterna att upptäckter som leder till Nobelpris görs på små biotechbolag. Ännu mer sällsynt är att arbetet bakom den prisbelönta forskni...

The impact of the recession on the Swedish medtech sector

We need health care regardless of whether the economy is good or bad, but the current recession also affects the Medtech sector.

Malmös forskningspark Medeon får ny vd

Malmös forskningspark för life science har rekryterat Malin Bornschein till ny vd.

“A major energy boost for the entire cancer vaccine field”

The development of cancer vaccines has accelerated in recent years. Norwegian Ultimovacs is one of the companies attempting to develop a new type of treatment l...

Abera får Vinnova-stöd för utveckling av nasalt pneumokockvaccin

Det svenska bioteknikföretaget Abera Bioscience får 1 miljon i stöd av Vinnova. Beloppet är avsedd för utvecklingen av bolagets nasala vaccin mot pneumokocker.

Novo Nordisk establishes new factory in Denmark

Novo Nordisk establishes a new production facility in Odense, Denmark, an investment of 8.5 billion Danish kroner.

Läkemedelsanvändning fokus för nytt forskningssamarbete

Läkemedelsverket och Uppsala universitet ingår nytt samarbete om läkemedelsepidemiologi. Parterna har nu tecknat en avsiktsförklaring.

Optimize Courier SUPPLIERS (DISTRIBUTORS)

Conference on Alzheimer’s reveals several advances in the field

In Gothenburg, Sweden, researchers and pharmaceutical companies from all over the world gathered to discuss one specific issue – neurological diseases. Life Sci...

Ingrid Lönnstedt: What does the p-value mean?

The smaller the better, and preferably smaller than 0.05. A p-value smaller than 5% means that the treatment effect is statistically significant at 5% significa...

Olof Akre blir forskningsdirektör på Karolinska

Olof Akre, professor i onkologisk kirurgi och verksamhetschef vid Tema Cancer, blir direktör för forskning, utbildning och utveckling, FoUU, vid Karolinska univ...

Licenspartner avbryter program – Sprint tar över

Sprint Bioscience licenspartner Deciphera Pharmaceuticals har meddelat bolaget att det inte avser driva VPS34-programmet vidare.

Webinar: Support Trial Patients Transitioning to the Commercial Space

Register for expert insights on supporting Phase III clinical trial patients post-approval and read our blog on advanced Patient Assistance Programs.

Uppsala-based company wins important patent dispute – but the decision is subject to appeal

A US district court has ruled in favour of Orexo in a dispute over the patent protecting the Swedish company’s drug Zubsolv, developed for treating patients wit...

KI’s new President: “We need to work closer together”

A closer link between research and education and a stronger “we-feeling” are aims that Annika Östman Wernerson sets out to achieve as the new President of Karol...

Festo liquid dispensing: going fast and slow

Dispensing liquid with Festo equipment developed for automation can really be adapted to your needs

ZEISS Insights: Measurement of bone plates and screws

Get free access to technical paper.

Mastering Urine Microscopy

On-demand Webinar: Microscopy in urinalysis.

Advancing Drug Discovery by Combining Complex In-Vitro Models with AI-Powered 3D/4D Image Analysis

Free webinar organized by ZEISS.

Combigene avslutar projekt efter ”svårtolkade data”

Genterapibolaget Combigene avbryter sitt prekliniska utvecklingsprojekt inom lipodystrofi. Enligt företaget saknas tillräckligt med övertygande data för att dri...

KI-studie: Nässköljning kunde ge information om KOL

Förekomsten av ett visst protein i näsan kunde användas som underlag för bedömning av KOL, i en ny studie från forskare vid Karolinska institutet.

AZ gets approval for drug targeting rare disease – it may reduce cortisone dependence

AstraZeneca’s drug Fasenra gets an expanded indication in the EU and is now approved as a treatment for the rare autoimmune disease known as Churg-Strauss syndrome.